Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Gene mutations have not yet been included in the 2016 WHO classification and revised International Prognostic Scoring System (IPSS-R), which are now widely utilized to discriminate myelodysplastic syndrome (MDS) patients regarding risk of leukemia evolution and overall survival (OS). In this study,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood Cancer J
Glavni autori: Hou, Hsin-An, Tsai, Cheng-Hong, Lin, Chien-Chin, Chou, Wen-Chien, Kuo, Yuan-Yeh, Liu, Chieh-Yu, Tseng, Mei-Hsuan, Peng, Yen-Ling, Liu, Ming-Chih, Liu, Chia-Wen, Liao, Xiu-Wen, Lin, Liang-In, Yao, Ming, Tang, Jih-Luh, Tien, Hwei-Fang
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884776/
https://ncbi.nlm.nih.gov/pubmed/29618722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0074-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items